Login

Li-Cycle CEO emphasizes top priority with scaled-back Rochester Hub and outlines a three-point plan. 00:10:00

Share On Facebook Share On Twitter

Ajay Kochhar is the President, CEO and co-founder of Li-Cycle.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Try to build great businesses and deliver strong returns to investors|Wong Teek Son,Executive Chairman,Riverstone Holdings
00:10:00
Aggregating Lithium Properties in Ontario and Expanding Exploration Efforts
00:10:00
Billionaire Discusses Distressed Real Estate Deals, China Relations, and 2024 Election Uncertainty
00:10:00
Vior's Hybrid Prospect Generator Model and Belter Gold Project Plans for 2024
00:10:00
"Join Mr. John Lai, CEO & President of PetVivo Holdings, Inc., for a revealing interview on the company's pioneering advancements and strategic vision."|Mr. Lai has been a director and senior executive officer of PetVivo Holdings.
00:10:00
Wirtualna Polska Holding SA provides information on its business activities and synergies across its main sectors—media and...
00:10:00
Lazard Conférence-Débat avec André Comte-Sponville | Peter Orszag, CEO, Lazard Fr�res Gestion SASAS OF 29 SEP 2023
00:10:00
helps entrepreneurs and invests in early stage B2B software based companies|Blake Modersitzki,Partner,Pelion Venture Partners
00:00:00
Inorganic Nitrate Benefits and Tolerability of Exercise Training - Dr. Barry Borlaug, a Cardiologist and Heart Failure Specialist at Mayo Clinic
00:10:00
Join us for an engaging podcast episode featuring Renaud de Viel Castel, COO and Head of Global Expansion at Rubicon Technologies, Inc.
00:10:00
Challenges and Opportunities in Electric Mobility and Circular Economy: Insights from a Speech | Renato Mazzoncini , CEO, A2A Spa.
00:10:00
Weathering Controversy and Forging Ahead in Finance | Michael Rees , co-founder , Blue Owl Capital .

© 2017 - Neuhu+